Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical HSCT with Reduced-Intensity Conditioning
NCT00740467Phase 2Unknown
- Sponsor
- Institut Paoli-Calmettes
- Start
- Jan 2008
- Primary completion
- Jan 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of hematopoietic stem cells in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), sponsored by Institut Paoli-Calmettes. Status: unknown.
02
Drugs
hematopoietic stem cells
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myelogenous leukemia (CML)multiple myeloma (MM)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00740467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740467.